Leading Edge Clinic
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury (NCT07567274) | Leading Edge Clinic | 2026-05-15 |
Track Leading Edge Clinic automatically
Every clearance here is in the API, with alerts when new ones post.